SMS Pharmaceuticals Adjusts Evaluation Score Amid Mixed Technical Indicators and Strong Financial Health
SMS Pharmaceuticals has recently adjusted its evaluation score, reflecting a change in technical trends. The company's financial health remains strong, with nine consecutive quarters of positive results, a notable operating profit to interest ratio, and a low debt-equity ratio, despite modest growth in net sales and operating profit.
SMS Pharmaceuticals, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, moving from a mildly bearish stance to a mildly bullish outlook. The company's technical indicators present a mixed picture. The MACD shows a mildly bearish trend on both weekly and monthly bases, while the Bollinger Bands indicate a bullish sentiment in the weekly timeframe and a mildly bullish stance monthly. Daily moving averages lean towards a mildly bullish perspective, suggesting some positive momentum.
In terms of financial health, SMS Pharmaceuticals has reported positive results for the last nine consecutive quarters, with an operating profit to interest ratio reaching a notable 8.05 times. The company also boasts cash and cash equivalents of Rs 41.59 crore, alongside a low debt-equity ratio of 0.49 times. Despite a modest annual growth rate in net sales and operating profit over the past five years, the company has seen a significant increase in profits, with a PEG ratio of 0.9 indicating fair valuation relative to its earnings growth.
The stock is currently trading at Rs 237.95, with a 52-week high of Rs 398.00 and a low of Rs 175.00.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
